A 7-day multicenter randomized double-blind, double-dummy parallel group trial to assess the safety and efficacy of 400 mg lumiracoxib once daily versus 500 mg naproxen twice daily in patients with acute musculoskeletal pain due to uncomplicated soft tissue injury

Trial Profile

A 7-day multicenter randomized double-blind, double-dummy parallel group trial to assess the safety and efficacy of 400 mg lumiracoxib once daily versus 500 mg naproxen twice daily in patients with acute musculoskeletal pain due to uncomplicated soft tissue injury

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Nov 2008

At a glance

  • Drugs Lumiracoxib; Naproxen
  • Indications Musculoskeletal pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Nov 2008 Results were reported in the International Journal of Clinical Practice.
    • 19 Oct 2006 Status change
    • 14 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top